Table 2.
Protocol/factor | GΔP (mmHg %−1) | ΔP100 (mmHg) | TΔP (min) |
---|---|---|---|
AM measurements – before sustained hypoxia | |||
Control 1 | 0.50 ± 0.06 | 18.9 ± 1.5 | 2.41 ± 0.41 |
Trimetaphan | 0.41 ± 0.04 | 17.4 ± 1.2 | 3.06 ± 0.32 |
Control 2 | 0.58 ± 0.06 | 17.9 ± 1.2 | 3.24 ± 0.20 |
PM measurements – after sustained hypoxia | |||
Control 1 | 0.95 ± 0.10 | 22.2 ± 1.8 | 3.90 ± 0.64 |
Trimetaphan | 0.68 ± 0.07 | 21.2 ± 1.6 | 2.91 ± 0.35 |
Control 2 | 0.82 ± 0.04 | 22.1 ± 1.4 | 3.61 ± 0.40 |
Statistical analysis – ANOVA | |||
Time (before/after sustained hypoxia) | < 0.001 | < 0.001 | — |
Protocol (C1, C2 versus T) | < 0.02 | < 0.05 | — |
Interactive term | — | — | < 0.05 |
GΔP is the sensitivity of maximum pressure difference across tricuspid valve during systole (ΔPmax) to a decrease in saturation; ΔP100 is the steady-state value for ΔPmax in the absence of hypoxia (i.e. when saturation is 100%); TΔP is the time constant for the response; AM, morning; PM, afternoon. ANOVA conducted on the parameter values with fixed factors Time (before/after sustained hypoxia) and Protocol (control protocols (Protocols C1, C2) versus Protocol T). Statistical significance was accepted at P < 0.05.